A detailed history of Wealth Effects LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Wealth Effects LLC holds 7,085 shares of NVO stock, worth $602,225. This represents 0.33% of its overall portfolio holdings.

Number of Shares
7,085
Previous 7,071 0.2%
Holding current value
$602,225
Previous $1.01 Million 16.45%
% of portfolio
0.33%
Previous 0.42%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$119.07 - $145.42 $1,666 - $2,035
14 Added 0.2%
7,085 $843,000
Q2 2024

Aug 02, 2024

SELL
$122.71 - $146.91 $117,433 - $140,592
-957 Reduced 11.92%
7,071 $1.01 Million
Q1 2024

Apr 22, 2024

SELL
$102.11 - $135.92 $560,583 - $746,200
-5,490 Reduced 40.61%
8,028 $1.03 Million
Q4 2023

Jan 29, 2024

BUY
$87.78 - $105.45 $696,709 - $836,956
7,937 Added 142.21%
13,518 $1.4 Million
Q3 2023

Oct 16, 2023

BUY
$90.94 - $199.54 $507,536 - $1.11 Million
5,581 New
5,581 $507,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Wealth Effects LLC Portfolio

Follow Wealth Effects LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Effects LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Effects LLC with notifications on news.